Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Why Ocugen Stock Topped the Market Today
10:28pm, Thursday, 01'st Sep 2022 The Motley Fool
The company appointed not one, but two new top managers to crucial posts.
This Overlooked Danger Could Tank Big Pharma Stocks
06:13pm, Thursday, 01'st Sep 2022
It started out relatively small, or as small as a recall of one of the first drugs to top $1 billion in annual sales can be. In September 2019, individual companies began recalling popular heartburn m
Outlook For Merck Continues To Be Favorable
05:25pm, Thursday, 01'st Sep 2022
Merck (MRK) has been turning in solid earnings in recent quarters. Revenue growth across a range of drug lines is robust.
Is Humira Maker A Better Bet Over Merck Stock?
09:00am, Thursday, 01'st Sep 2022
There is more to the comparison, and in the sections below, we discuss why we believe ABBV stock will offer better returns than MRK stock in the next three years.
Why Guardant Health Crushed the Market Today
10:40pm, Wednesday, 31'st Aug 2022 The Motley Fool
The company deepened its relationship with an important peer.
Mario Gabelli's Gabelli Asset Fund 2022 Semiannual Report
06:27pm, Wednesday, 31'st Aug 2022
To Our Shareholders,
U.S. plans to move COVID vaccines, treatments to private markets in 2023
06:10pm, Tuesday, 30'th Aug 2022
The U.S. government expects its supply of COVID-19 vaccines and antiviral treatments to run out over the next year and is preparing for them to be sold via the commercial market, the Department of Hea
Two-Minute Drill: Nike, Merck & Ferguson
05:25pm, Monday, 29'th Aug 2022
Nicole Webb, Wealth Enhancement Group senior vice president, joins ‘Closing Bell: Overtime' to give her take on Nike, Merck and Ferguson.
Company News for Aug 29, 2022
01:37pm, Monday, 29'th Aug 2022 Zacks Investment Research
Companies in The News Are: AFRM,FTCH,SGEN,MRK,DELL
The Zacks Analyst Blog Highlights Novartis, J&J, AbbVie, Merck and Pfizer
11:43am, Monday, 29'th Aug 2022 Zacks Investment Research
Novartis, J&J, AbbVie, Merck and Pfizer are part of The Zacks top Analyst Blog.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that research spanning 16 different cancer types will be presented
Iovance (IOVA) Starts Rolling BLA With FDA for Melanoma Therapy
05:13pm, Friday, 26'th Aug 2022 Zacks Investment Research
Iovance (IOVA) starts a rolling BLA submission with the FDA seeking approval for its lead pipeline candidate in advanced melanoma patients. The filing is expected to be completed by fourth-quarter 202
Pharma Stock Roundup: NVS to Spin Off Sandoz; JNJ, MRK, ABBV's FDA Updates
01:09pm, Friday, 26'th Aug 2022 Zacks Investment Research
Novartis (NVS) plans to spin off its generics division, Sandoz. The FDA approves J&J (JNJ) and AbbVie's (ABBV) Imbruvica for pediatric indication cGVHD.
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
01:00pm, Friday, 26'th Aug 2022 Zacks Investment Research
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Bristol Myers (BMY) Up 14.6% YTD: Will the Performance Continue?
12:43pm, Friday, 26'th Aug 2022 Zacks Investment Research
Bristol Myers (BMY) has put up an impressive performance so far in 2022, and the momentum should continue on label expansion of existing drugs.
